Last reviewed · How we verify
OTC Eczema Moisturizer Regimen — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
OTC Eczema Moisturizer Regimen (OTC Eczema Moisturizer Regimen) — Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| OTC Eczema Moisturizer Regimen TARGET | OTC Eczema Moisturizer Regimen | Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- OTC Eczema Moisturizer Regimen CI watch — RSS
- OTC Eczema Moisturizer Regimen CI watch — Atom
- OTC Eczema Moisturizer Regimen CI watch — JSON
- OTC Eczema Moisturizer Regimen alone — RSS
Cite this brief
Drug Landscape (2026). OTC Eczema Moisturizer Regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/otc-eczema-moisturizer-regimen. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab